JUBLINGREA · Basic Materials · Specialty Chemicals
Composite scorecard: 38/100 — Quality 43 · Valuation 26 · Momentum 46
| Share price | ₹736.85 |
| Market cap | ₹9,255 Cr |
| P/E ratio | 35.0 |
| P/B ratio | 3.0 |
| ROE | 17.3% |
| ROCE | 11.0% |
| Dividend yield | 0.85% |
| Book value | ₹192.60 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹4,388 Cr | ₹278 Cr | 13.0% |
| 2025 | ₹4,178 Cr | ₹251 Cr | 12.0% |
| 2024 | ₹4,136 Cr | ₹183 Cr | 10.0% |
| 2023 | ₹4,773 Cr | ₹308 Cr | 11.0% |
| 2022 | ₹4,949 Cr | ₹477 Cr | 17.0% |
Jubilant Ingrevia Limited engages in life science products and solutions in India, the United States, Europe, China and internationally. The company operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions. The Nutrition & Health Solutions segment provides nutrition and health ingredients; and animal and human nutrition health solutions. The Chemical intermediates segm